Qualcomm’s Irwin Jacobs joins biotech company’s board
Jacobs, 84, has retired from
Biological Dynamics marries biomedical science with high-tech in the form of "lab on a chip" tests for cancer. The privately held company says its technology can quickly isolate nanoparticles that carry information on disease.
Cancer is the first disease the company is tackling. It eventually wants to make automated testing inexpensive and available, including access outside traditional medical settings.
"As one of our earliest investors, Irwin has a deep understanding of our ability to transform the way cancer is detected and diagnosed, CEO
Also joining the board is
(619) 293-1020
___
(c)2018 The San Diego Union-Tribune
Visit The San Diego Union-Tribune at www.sandiegouniontribune.com
Distributed by Tribune Content Agency, LLC.
Global Digital Health Market – Insights and Trends 2016-2024
OPINION: Luke Mayville and his Medicaid for Idaho campaign are proving us political ‘experts’ wrong
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News